Stifel Financial Corp Blueprint Medicines Corp Transaction History

Stifel Financial Corp

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $24,765 - $38,539	-496 Reduced 2.72%	17,737 $1.17 Million
Q2 2022 Aug 15, 2022	SELL	$45.23 - $70.15 $74,946 - $116,238	-1,657 Reduced 8.33%	18,233 $921,000
Q1 2022 May 13, 2022	SELL	$54.1 - $110.08 $10,711 - $21,795	-198 Reduced 0.99%	19,890 $1.27 Million
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $51,931 - $63,910	-551 Reduced 2.67%	20,088 $2.15 Million
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $1.4 Million - $1.9 Million	17,348 Added 527.13%	20,639 $2.12 Million
Q2 2021 Aug 13, 2021	BUY	$82.78 - $101.0 $69,617 - $84,941	841 Added 34.33%	3,291 $289,000
Q1 2021 May 14, 2021	SELL	$90.71 - $108.28 $1,088 - $1,299	-12 Reduced 0.49%	2,450 $238,000
Q4 2020 Feb 12, 2021	SELL	$92.08 - $124.48 $72,559 - $98,090	-788 Reduced 24.25%	2,462 $276,000
Q3 2020 Nov 16, 2020	SELL	$66.45 - $92.7 $33,291 - $46,442	-501 Reduced 13.36%	3,250 $301,000
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $214,144 - $297,341	3,751 New	3,751 $293,000
Q1 2020 May 14, 2020	SELL	$48.11 - $82.22 $164,776 - $281,603	-3,425 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$66.73 - $82.59 $228,550 - $282,870	3,425 New	3,425 $275,000
Q3 2019 Nov 13, 2019	SELL	$72.9 - $101.41 $759,253 - $1.06 Million	-10,415 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $765,919 - $1.02 Million	10,415 New	10,415 $983,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.